Pleiotropic preventive effects of dietary polyphenols in cardiovascular diseases

European Journal of Clinical Nutrition

Volumn 67, Issue 5, 2013, Pages 532-535

  Kishimoto, Y ^a   Tani, M ^a   Kondo, K ^a  

^a OCHANOMIZU UNIVERSITY   (Japan)

Author keywords

CVD; lipid metabolism; polyphenol; vascular inflammation

Indexed keywords

CATECHIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; POLYPHENOL;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BEVERAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COFFEE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY INTAKE; ENDOTHELIAL DYSFUNCTION; FOOD COMPOSITION; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID OXIDATION; METABOLIC DISORDER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PLEIOTROPY; POSTPRANDIAL STATE; REVIEW; RISK REDUCTION; TEA; VASCULITIS;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIET; HUMANS; PHYTOTHERAPY; PLANT PREPARATIONS; POLYPHENOLS;

EID: 84877152770     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2013.29     Document Type: Review

References (58)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924
2. Dauchet L, Amouyel P, Dallongeville J. Fruits, vegetables and coronary heart disease. Nat Rev Cardiol 2009; 6: 599-608
3. Hertog MG, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet 1997; 349: 699
4. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of USA adults. Am J Clin Nutr 2012; 95: 454-464
5. Neveu V, Perez-Jimenez J, Vos F, Crespy V, du Chaffaut L, Mennen L et al. Phenolexplorer: An online comprehensive database on polyphenol contents in foods. Database (Oxford) 2010, 2010: Bap024
6. Kesse-Guyot E, Fezeu L, Andreeva VA, Touvier M, Scalbert A, Hercberg S et al. Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later. J Nutr 2012; 142: 76-83
7. George S, Brat P, Alter P, Amiot MJ. Rapid determination of polyphenols and vitamin C in plant-derived products. J Agric Food Chem 2005; 53: 1370-1373
8. Fukushima Y, Ohie T, Yonekawa Y, Yonemoto K, Aizawa H, Mori Y et al. Coffee and green tea as a large source of antioxidant polyphenols in the Japanese population. J Agric Food Chem 2009; 57: 1253-1259
9. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337: 408-416
10. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526
11. Kondo K, Matsumoto A, Kurata H, Tanahashi H, Koda H, Amachi T et al. Inhibition of oxidation of low-density lipoprotein with red wine. Lancet 1994; 344: 1152
12. Kondo K, Hirano R, Matsumoto A, Igarashi O, Itakura H. Inhibition of LDL oxidation by cocoa. Lancet 1996; 348: 1514
13. Ohmori R, Iwamoto T, Tago M, Takeo T, Unno T, Itakura H et al. Antioxidant activity of various teas against free radicals and LDL oxidation. Lipids 2005; 40: 849-853
14. Kamiyama M, Kishimoto Y, Tani M, Andoh K, Utsunomiya K, Kondo K. Inhibition of low-density lipoprotein oxidation by Nagano purple grape (Vitis vinifera-Vitis labrusca). J Nutr Sci Vitaminol (Tokyo) 2009; 55: 471-478
15. Nagai M, Tani M, Kishimoto Y, Iizuka M, Saita E, Toyozaki M et al. Sweet potato (Ipomoea batatas L.) leaves suppressed oxidation of low density lipoprotein (LDL) in vitro and in human subjects. J Clin Biochem Nutr 2011; 48: 203-208
16. Saita E, Kishimoto Y, Tani M, Iizuka M, Toyozaki M, Sugihara N et al. Antioxidant activities of Perilla frutescens against low-density lipoprotein oxidation in vitro and in human subjects. J Oleo Sci 2012; 61: 113-120
17. van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002; 360: 1477-1478
18. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: A systematic review with meta-Analysis. Arch Intern Med 2009; 169: 2053-2063
19. Iso H, Date C, Wakai K, Fukui M, Tamakoshi A. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 2006; 144: 554-562
20. Torronen R, Sarkkinen E, Tapola N, Hautaniemi E, Kilpi K, Niskanen L. Berries modify the postprandial plasma glucose response to sucrose in healthy subjects. Br J Nutr 2009; 103: 1094-1097
21. Wilson T, Singh AP, Vorsa N, Goettl CD, Kittleson KM, Roe CM et al. Human glycemic response and phenolic content of unsweetened cranberry juice. J Med Food 2008; 11: 46-54
22. Hlebowicz J, Darwiche G, Bjorgell O, Almer LO. Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am J Clin Nutr 2007; 85: 1552-1556
23. Gin H, Rigalleau V, Caubet O, Masquelier J, Aubertin J. Effects of red wine, tannic acid, or ethanol on glucose tolerance in non-insulin-dependent diabetic patients and on starch digestibility in vitro. Metabolism 1999; 48: 1179-1183
24. Thom E. The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-Term in overweight and obese people. J Int Med Res 2007; 35: 900-908
25. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: An eight-year follow-up in the Copenhagen Male Study. Circulation 1998; 97: 1029-1036
26. Vinson JA, Dabbagh YA. Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in the hamster: Mechanisms for the epidemiological benefits of tea drinking. FEBS Lett 1998; 433: 44-46
27. Chan PT, Fong WP, Cheung YL, Huang Y, Ho WK, Chen ZY. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr 1999; 129: 1094-1101
28. Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 1995; 310: 693-696
29. Sanders TA. Dietary fat and postprandial lipids. Curr Atheroscler Rep 2003; 5: 445-451
30. Mero N, Syvanne M, Taskinen MR. Postprandial lipid metabolism in diabetes. Atherosclerosis 1998; 141(Suppl 1): S53-S55
31. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428
32. Shepherd J, Betteridge J, Van Gaal L. Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: A position paper developed by a European Consensus Panel. Curr Med Res Opin 2005; 21: 665-682
33. Kondo K, Hosoda K, Iwamoto T, Kusumoto A, Hirano R, Matsumoto A et al. Red wine improves postprandial status. In Symposium on Drugs Affecting Lipid Metabolism Florence, Italy, 1998
34. Toyoda-Ono Y, Yoshimura M, Nakai M, Fukui Y, Asami S, Shibata H et al. Suppression of postprandial hypertriglyceridemia in rats and mice by oolong tea polymerized polyphenols. Biosci Biotechnol Biochem 2007; 71: 971-976
35. Nakai M, Fukui Y, Asami S, Toyoda-Ono Y, Iwashita T, Shibata H et al. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agric Food Chem 2005; 53: 4593-4598
36. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988; 8: 737-741
37. Asztalos BF, Tani M, Schaefer EJ. Metabolic and functional relevance of HDL subspecies. Curr Opin Lipidol 2011; 22: 176-185
38. Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: A systematic review and meta-Analysis of randomized trials. Am J Clin Nutr 2012; 95: 740-751
39. Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res 1968; 9: 155-167
40. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 2004; 101: 9774-9779
41. Bortnick AE, Rothblat GH, Stoudt G, Hoppe KL, Royer LJ, McNeish J et al. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 2000; 275: 28634-28640
42. Wang N, Silver DL, Thiele C, Tall AR. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem 2001; 276: 23742-23747
43. Kennedy MA, Barrera GC, Nakamura K, Baldan A, Tarr P, Fishbein MC et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 2005; 1: 121-131
44. Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997; 272: 20982-20985
45. Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. HDL and cardiovascular disease: Atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 2011; 8: 222-232
46. Rosenblat M, Volkova N, Coleman R, Almagor Y, Aviram M. Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: Enhanced macrophage cholesterol efflux. J Nutr Biochem 2008; 19: 514-523
47. Uto-Kondo H, Ayaori M, Ogura M, Nakaya K, Ito M, Suzuki A et al. Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages. Circ Res 2010; 106: 779-787
48. Li L, Tatake RJ, Natarajan K, Taba Y, Garin G, Tai C et al. Fluid shear stress inhibits TNF-mediated JNK activation via MEK5-BMK1 in endothelial cells. Biochem Biophys Res Commun 2008; 370: 159-163
49. Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res 2007; 101: 234-247
50. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes Jr. DR, Lerman A. Longterm follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-954
51. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-Term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906
52. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241
53. Karatzis EN, Ikonomidis I, Vamvakou GD, Papaioannou TG, Protogerou AD, Andreadou I et al. Long-Term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am J Cardiol 2006; 98: 1424-1428
54. Hashimoto M, Kim S, Eto M, Iijima K, Ako J, Yoshizumi M et al. Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. Am J Cardiol 2001; 88: 1457-1460A1459
55. Heiss C, Kleinbongard P, Dejam A, Perre S, Schroeter H, Sies H et al. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol 2005; 46: 1276-1283
56. Vlachopoulos C, Aznaouridis K, Alexopoulos N, Economou E, Andreadou I, Stefanadis C. Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens 2005; 18: 785-791
57. Alexopoulos N, Vlachopoulos C, Aznaouridis K, Baou K, Vasiliadou C, Pietri P et al. The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiovasc Prev Rehabil 2008; 15: 300-305
58. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-Analysis of randomized controlled trials. Am J Clin Nutr 2008; 88: 38-50